Business Standard

Indoco Remedies hits 8-month high on hopes of margin boost; stock surges 7%

In the past one week, it rallied 17 per cent, as against 0.35 per cent rise in the S&P BSE Sensex

pharma
Premium

SI Reporter Mumbai
Shares of Indco Remedies soared 7 per cent to hit an eight-month high of Rs 414.85 in Thursday’s intra-day trade, on hopes of margin improvement going ahead.

The stock of pharmaceutical company traded at its highest level since March 2022. In the past one week, it rallied 17 per cent, as against 0.35 per cent rise in the S&P BSE Sensex. Earlier, the stock had hit a 52-week high of Rs 459 on January 3, 2022.

Indoco manufactures and markets branded formulations and APIs for domestic and export markets. In domestic formulations, the company serves a range of

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 24 2022 | 2:44 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com